Join a team of experts dedicated to improving the lives of patients and families through gene therapy.
We have a bold mission, but Axovia Therapeutics is committed to achieving it by hiring top talent, fostering a unique, collaborative culture and driving a thoughtful pipeline targeting diseases where a one-time gene therapy solution can have a major impact on the trajectory of a person’s life.
The postholder will hold a high interest in animal care and have previous experience in animal husbandry within a research environment. This role will be based in the Biological Support Unit (BSU), where the successful candidate will assist with basic husbandry routines as well as contribute to the upkeep of the Facility.
They will have great knowledge and understanding of The Animal Scientific Procedures Act 1986 and hold and maintain a Home Office Personal Licence, modules AB&C.
To maintain high standards of hygiene levels and best practice animal welfare within the BSU. To ensure and monitor these are kept in accordance with legal requirements.
The post holder will be responsible for the supervision of staff, other categories of workers (i.e. maintenance staff) and visitors who have been authorised by Management to access the BSU.
The post holder will report to the Facility Manager and ultimately to the Lab Director and CSO. This is a full–time position based in the King’s Cross area of London, offering a competitive salary, private healthcare scheme, bonus scheme, Employee Stock Ownership Plan’s, enhanced annual leave and more.
The closing date for this position is Monday, 13th December 2021.
About Axovia Therapeutics
Axovia Therapeutics, Inc., is accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases. Axovia leverages a proven management team with the expertise to accelerate the development, manufacturing and commercialisation of novel gene therapy treatments for the patients, families and communities looking for hope.
Axovia Therapeutics is focused on creating transformative therapies for ciliopathies, is advancing AXV101, a gene therapy treatment for BBS1, a subset of Bardet-Biedl syndrome (BBS). A life-threatening neurometabolic condition, BBS causes progressive vision loss, severe obesity, learning disorders and kidney disease.
Axovia Therapeutics is proud to be an equal opportunity workplace. We are committed to equal employment opportunity regardless of race, colour, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity or Veteran status. If you have a disability or special need that requires accommodation, please let us know.
Please apply now by clicking the Apply Button above.
|Location:||Kings Cross, London|
|Placed On:||29th November 2021|
|Closes:||13th December 2021|
Type / Role: